Stock MAAT MAAT PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases MaaT Pharma

Equities

MAAT

FR0012634822

Real-time Euronext Paris
Other stock markets
 06:09:45 2024-05-23 am EDT 		5-day change 1st Jan Change
7.94 EUR +0.51% Intraday chart for MaaT Pharma +0.51% +13.75%
May. 08 Mickey Mouse on Wall Street Our Logo
Apr. 15 MaaT Pharma: positive data in graft-versus-host disease CF

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
May 15, 2024: MaaT Pharma announces the successful completion of its Global Offering of 19.2 Million Euros
PU
MaaT Pharma announces the successful completion of its Global Offering of 19.2 Million Euros
BU
MaaT Pharma : Inside Information / News release on accounts, results
PU
MaaT Pharma Launches a Global Offering of approximately 18 Million Euros
BU
May 14, 2024: MaaT Pharma Launches a Global Offering of approximately 18 Million Euros
PU
MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2024
BU
MaaT Pharma to Hold Annual General Meeting on May 28, 2024
BU
Long-term data indicates "significant" potential of aGvHD microbiome treatment
AQ
MaaT Pharma Presents Positive 18-month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event
BU
Advancing microbiome innovation
AQ
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses to Immunotherapies
BU
MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont, Groupe Societe Generale
AQ
MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale
BU
MaaT Pharma Announces 2023 Annual Results and Provides a Business Overview
BU
MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer
BU
MaaT Pharma to Present New Preclinical Data at AACR for MaaT034 Aiming To Improve Patients Responses to Immunotherapies
AQ
MaaT Pharma To Present New Preclinical Data at AACR for MaaT034 Aiming To improve Patients’ Responses to Immunotherapies
BU
MaaT Pharma : Inside Information / Other news releases
PU
MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be Presented at the Upcoming EBMT Conference
BU
MaaT Pharma Releases its 2024 Financial Calendar
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MAAT Stock
  4. News MaaT Pharma
  5. Press Releases